Arbutus Biopharma Corporation
ABUS
$2.75
$0.000.00%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/18/2024
-
Globe Newswire
4/16/2024
-
Zolmax
4/10/2024
-
SeekingAlpha
4/5/2024
-
Ticker Report
4/4/2024
-
TipRanks Financial Blog
4/4/2024
-
Globe Newswire
4/4/2024
-
Simply Wall St
4/4/2024
-
Benzinga
4/3/2024
-
Benzinga
4/3/2024
-
Seeking Alpha - Healthcare
3/26/2024
-
Zolmax
3/25/2024
-
The Fly
3/20/2024
-
The Fly
3/18/2024
-
Zolmax
3/15/2024
-
Stock Options Channel
3/14/2024
-
Zolmax
3/8/2024
-
TipRanks Financial Blog
3/8/2024
-
Globe Newswire
3/4/2024
-
Zolmax
3/2/2024
-
Ticker Report
3/2/2024
-
Ticker Report
3/1/2024
-
The Fly
3/1/2024
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 5, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
267 469 0914
Address
701 Veterans Circle
Warminster, PA 18974
Warminster, PA 18974
Country
Year Founded
--
Business Description
Sector
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of...
more
